// App-Quantinova.ai

351 : Next-Generation Sequencing and Real-Time Quantitative PCR For Quantification Of Low-Level Minimal Residual Disease In Acute Lymphoblastic Leukemia Of Adults

Researchers

Presenter

  • Monika Bruggemann

Principal Investigators

  • Matthias Ritgen

  • Marco Ladetto

  • Francois Pepin

  • Heiko Trautmann

  • Victoria Carlton

  • Dieter Hoelzer

  • Nicola Gokbuget

  • Michael Kneba

  • Malek Faham

  • Christiane Pott

Medical Centers

  • Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  • Infektiologikum, Frankfurt/Main, Germany

  • Dept of Pediatrics, University Hospital Frankfurt, Frankfurt, Germany

  • Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

Locations

  • Germany

Companies

  • Sequenta, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved